A Preliminary Risk-Benefit Assessment of Latanoprost and Unoprostone in Open-Angle Glaucoma and Ocular Hypertension

被引：0
|
作者：
Dan L. Eisenberg
Carl B. Camras
机构：
[1] University of Nebraska Medical Center,Department of Ophthalmology
[2] 985540 Nebraska Medical Center,undefined
来源：
Drug Safety | 1999年 / 20卷
关键词：
Glaucoma; Adis International Limited; Intraocular Pressure; Timolol; Latanoprost;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Latanoprost and unoprostone (isopropyl unoprostone) represent the first commercially available prostaglandin analogues to be used for the treatment of glaucoma. Both compounds reduce intraocular pressure by enhancing uveoscleral outflow.
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [41] Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension
    Thomas Mundorf
    Robert J. Noecker
    Melissa Earl
    Advances in Therapy, 2007, 24 : 302 - 309
  • [42] Ocular hypotensive efficacy of brimonidine 0.15% as adjunctive therapy with latanoprost 0.005% in patients with open-angle glaucoma or ocular hypertension
    Mundorf, Thomas
    Noecker, Robert J.
    Earl, Melissa
    ADVANCES IN THERAPY, 2007, 24 (02) : 302 - 309
  • [43] Risk of ocular hypertension or open-angle glaucoma in elderly patients on oral glucocorticoids
    Garbe, E
    LeLorier, J
    Boivin, JF
    Suissa, S
    LANCET, 1997, 350 (9083): : 979 - 982
  • [44] Headaches related to latanoprost in open-angle glaucoma
    Wang, Henrietta
    Masselos, Katherine
    Kalloniatis, Michael
    Phu, Jack
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2021, 104 (05) : 625 - 633
  • [45] Hypotensive efficacy in primary open-angle glaucoma and ocular hypertension: latanoprost in monotherapy vs timolol and dorzolamide in association
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2000, 78 : 49 - 50
  • [46] Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension
    Aptel, Florent
    Choudhry, Reena
    Stalmans, Ingeborg
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (08) : 1457 - 1463
  • [47] Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
    Aihara, Makoto
    Lu, Fenghe
    Kawata, Hisashi
    Iwata, Akihiro
    Odani-Kawabata, Noriko
    Shams, Naveed K.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 220 : 53 - 63
  • [48] Noninferiority Study Comparing Latanoprost 0.005% Without Versus With Benzalkonium Chloride in Open-Angle Glaucoma or Ocular Hypertension
    Wirta, David
    Malhotra, Ranjan
    Peace, James
    Lee, Bridgitte Shen
    Mitchell, Brittany
    Sall, Kenneth
    McMenemy, Matthew
    EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (04): : 149 - 154
  • [49] MERCURY-3: a randomized comparison of netarsudil/latanoprost and bimatoprost/timolol in open-angle glaucoma and ocular hypertension
    Ingeborg Stalmans
    Kin Sheng Lim
    Francesco Oddone
    Marek Fichtl
    Jose I. Belda
    Anton Hommer
    Guna Laganovska
    Cédric Schweitzer
    Bogomil Voykov
    Tomasz Zarnowski
    Gábor Holló
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 179 - 190
  • [50] A persistency and economic analysis of latanoprost, bimatoprost, or beta-blockers in patients with open-angle glaucoma or ocular hypertension
    Day, DG
    Schacknow, PN
    Sharpe, ED
    Ellyn, JC
    Kulze, JC
    Threlkeld, AB
    Jones, ED
    Brown, RH
    Jenkins, JN
    Stewart, WC
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 20 (05) : 383 - 392
12345